Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Jazz Pharma Plc (NASDAQ: JAZZ)

$150.61 USD -$1.36 (-0.89%)
Last Price $150.61
Net Change $-1.36 (-0.89%)
Bid $103.07
Ask Price $0
Open Price $153.21
Previous Close Price $151.97
High Price $153.21
Low Price $149.5
Number of Trades 1,407
Volume 246,631
Fifty Two Week High $163.75 (2017-04-28)
Fifty Two Week Low $95.8 (2016-11-04)
Average Daily Volume 574,748
Share Outstanding 60,030 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $2.31 (2017-05-09)
2nd Quarter Earnings $2.71 (2017-02-28)
3nd Quarter Earnings $2.57 (2016-11-08)
4th Quarter Earnings $2.63 (2016-08-09)
PE Ratio $20.49
EPS Growth $13.73
Recent Earnings $2.31
Annual EPS $7.28
Last Quarter EPS $
Market Capitalization $9.04B
Insider Shareholders % 0.039%
Annual Revenue $0B
No. Shares Outstanding 60,030
Inst. Shareholder % 88.56%
Annual Net Income $0.4B
TTM Net Profit Margin $26.78
1-Year Return 2.51%
3-Year Return 6.77%
5-Year Return 238.31%
5-Year Revenue Growth 446.49%
5-Year Earnings Growth 104.79%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 13.73%
Dividends per Share $
Stock Split Ratio
Beta 1.25
Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. Company's goal is to build a broad portfolio of products through a combination of internal development and acquisition/in-licensing activities and to utilize our specialty sales force to promote products in our target markets. They apply novel formulations and drug delivery technologies to known drug compounds, and compounds with the same mechanism of action or similar chemical structure as marketed products, to improve patient care by improving efficacy, reducing adverse side effects or increasing patient compliance relative to existing therapies. Based in Palo Alto, California, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals.